Always up to date.

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

Medartis announces resignation of CEO Christoph Brönnimann

Medartis announces that its CEO, Christoph Brönnimann, has decided to resign from his position and leave the company to pursue other opportunities. Christoph will continue to lead Medartis until a...

Read more

New Scaphoid System for APTUS Hand*

The new Scaphoid System 1.5-3.0 sets new standards: Additional scaphoid plates and a dedicated container - including CCS – offer extended options for the treatment of scaphoid non-unions and...

Read more

Press release 2024 annual general meeting

The shareholders of Medartis Holding AG (SIX: MED) today approved all the substantive proposals of the Board of Directors with a clear majority of more than 94.8%. All members of the Board of...

Read more